Reddit Posts
BSX Earnings. Another undervalued MedTech name.
Top stocks hitting 52-Week Highs/Lows - July 20, 2026 📈 📉
ISRG was call-heavy before earnings and still dumped nearly 10% after hours. Options flow doesn't tell the whole story
ISRG dropped Earnings aftermarket. Stock Falling.
Top stocks hitting 52-Week Highs/Lows - July 15, 2026 📈 📉
Top stocks hitting 52-Week Highs/Lows - July 14, 2026 📈 📉
Low snowfall, big opportunity.
Top stocks hitting 52-Week Highs/Lows - June 2, 2026 📈 📉
Top stocks hitting 52-Week Highs/Lows - June 1, 2026 📈 📉
Top stocks hitting 52-Week Highs/Lows - May 27, 2026 📈 📉
Interpreting Watchlist that still has high PE Ratios.
ISRG: Intuitive Surgical Q4 Earnings Call - Live Transcript on WallStreetBets
Congress Insider Trade Alert: Senator on Subcommittee Over Fish & Wildlife Buys Water Treatment Stock
Best buy and hold stocks over the past 20 years
Best buy and hold stocks over the past 20 years in S&P500
How to optimize long-term gains in my portfolio?
Top Oversold/Overbought Stocks - September 4, 2025 📊
MBOT (Microbot Medical) – FDA Catalyst Around the Corner
Intuitive Surgical $ISRG ($526.98) Downgraded by Deutsche Bank. My Take
Intuitive Surgical $ISRG ($524.35): Options Flow Analysis
I strongly believe robotics will be the biggest AI trade of all.
MedTech Companies I’m Excited to Watch in 2024: $SHLT $BFLY $ME $ISRG
I think ISRG Intuitive Surgical, will start tanking and so buying puts is my play. Please read. There are only 2 FDA apprvd Surgical Robots
Please analyze ISRG's market cap & ASXC's Market cap, it will give an idea of where ASXC is headin
Please analyze ISRG's market cap and ASXC's Market cap, it will give an idea of where ASXC is heading towards.$ASXC Only Two FDA General Surgical Robots approved for the Market.
Please analyze ISRG's market cap and ASXC's Market cap, it will give an idea of where ASXC is heading towards.$ASXC Only Two FDA General Surgical Robots approved for the Market.
Please analyze ISRG's market cap and ASXC's Market cap, it will give an idea of where ASXC is heading towards.
Insider Trading Weekly Update #036: 6 Insiders at Intuitive Surgical Sell Combined ~$35M, Regional Banks Catch a Bid - Insider Trading Recap
Hot Stocks: NDAQ, ISRG fall on earnings news; SHOP raises prices; NWS climbs
Diversified Portfolio with Individual US stocks - 2023
SNAP thunders again! ISRG rose 12% after the financial report!
CNBC's Jim Cramer recommends to Buy Intuitive Surgical, Inc. (ISRG). Currently, ISRG is down 43.18% so far this year and is currently $204.57. Has it found its bottom or is this recommendation going to flop?
robot assisted surgery - Intuitive / Asensus - I don't get it, but where to look?
Companies known for making excellent products in industries where excellence is critical
I think metaverse has enormous potential, and Fb has the best chance of executing it
Should I liquidate my stocks to pay for credit card debts?
Piper Jaffray puts $16 price target on Vicarious Surgical (RBOT) - former D8 Holdings - link to report included
Why did price of Intuitive Surgical (ISRG) fall crazy?
High potential $ASXC 1.88$ per share vs $ISRG 1000$ per share. And lawsuits against Intuitive.
MOST PESSIMISTIC TICKERS/CRYPTOS of this past week (8/30 - 9/3)
Thoughts on broader SPAC market conditions and three names to consider (GENI, DEH, JBI)
ISRG, Intuitive Surgical, acquisition letter because robots plus lasers = pretty fucking cool! 😎
TMDI finally seeing movement prior to earnings on May 17
Asensus Surgical (ASXC), a penny stock without short term risk!
close to 4% gains today. great day. ISRG was awesome. Waited for the 888.88 SP. LOL. can't lose. Moon shot soon!!
ISRG. Earnings big beat. Nice spike AH. let's see if it carries through tomorrow. Stock split eventually once stock hovers around 900$ if history is any indication. To The MOON!!
NrdRage's Friday DD: A robot may not injure a human being, sure, but is it injury if the robot just makes you go broke? Today we answer that question and dividing by 0 ($ISRG)
What’s going on w/ ASXC? Should be killin ISRG soon eh? What u guys think? Don’t kill me if I shouldn’t post a legit question
Mentions
Whats up with ISRG?
VOO - 50% VXUS - 25% ISRG - 10% NVDA - 5% USAR - 5% CEG - 5% I'm 24 studying mechanical engineering & I want to start investing long term. How much should I put in roth ira vs taxable accounts? Any advice on the port is welcome I'm going for a basic core-satellite structure.
Anyone here been bagholding ISRG? Think this is the quarter they finally turn it around and the stock starts an upward trend?
ISRG for starters, tho the move is already underway
Yes, ISRG, NOW, Lam Research, and GEV are among stocks I own that could be expensive but I don't care. If they go down I'll happily buy more of any of those 4 companies. Mixing in low beta stocks can help if your worried about volitility.
For me personally, I like to keep my high conviction bets between 4-7%, mid like 2-5, small like 1-3. I also work in the tech space, I have really high conviction on sk and mu over the next 3 years (think conservatively 20%+ cagr for next 3 years), as well as anet. No thoughts on APLD or Oracle, I think oracle is running a lot more deb than I personally like, but I also haven't researched them enough. If I was buying tomorrow, the following are all at good valutaions: ISRG, MELI, MU, SKHY, ANET, MCO/SPGI, NFLX
I think you need a tad more diversification. Sure, you have multiple ticker names, but let's be real, a large percentage of the movement is going to mirror one another. I would recommend diversifying into non tech names, see what has a strong cagr over the next 5 years. Top of list names are: \- ISRG: basically the Costco setup in scrubs \- MCO/SPGI: ratings tollbooths and a recurring analytics/data businesses \- NFLX: needs no explanation, people aren't going to stop watching shows, sticky business Just my two cents
goddammit i really want to pull the trigger on ISRG while its below 400 holy shit
Can I get one more $8-$9 run day on ISRG ?
Let's see. What would AAPL, MSFT, AMZN, WFC, ISRG, V, NFLX have gained if that were my portfolio? Because if I were to have picked individual stocks way back in 2016, these would have been the likely names.
"People sell stock for a dozen reasons, but they generally buy it for one." Jeff Green bought $150M of TTD around $24 in March. It got down to the $12's and is now $14. "What actually happened to BSX this year? " What happened to a lot of medtech. It's been a lousy year for a lot of names - look at ISRG, GEHC, etc. BSX cut guidance twice already this year, you've had rising competition and other issues. A lot of these names were also not exactly cheap to begin with and the series of concerns caused a considerable re-rating lower. IMHO, selectively buying a little of this sort of thing is certainly fine, but the problem IMO becomes people pile into stuff like this that's down a lot and then it doesn't turn around right away while all the stuff that is popular continues to be popular and they quickly lose patience. There was someone recently who has piled into NKE because "well, it's Nike and it's got to turn around right?" "NKE can't go below 40" becomes "NKE can't go below 35." Meanwhile, they're not looking at the fact that much of the industry is struggling, which doesn't exactly help matters.
i bought NXPI RMBS SYK ISRG WM
Nvda , Goog , nbis , ISRG , oust
Took some off the table. Bought some ISRG stock with the rest. Seems beaten down for such a large moat. Thank you sir
Are my November ISRG calls safe?
P&G, McDonald’s, Unilever, BSX, ISRG
Entered ISRG at $400. It's clearly a buy now but not the new Apple or Google of robotics.
ISRG, COST, JPM. You won’t go wrong with those three holding long.
I disagree on the momentum loss argument. Utilization is still climbing at the same rate it was a year ago and recurring revenue is 85% of the total and growing 19%, instruments & accessories revenue per procedure rose in Q2, FCF is up 75% YTD y/y. They placed 468 systems in Q2 (18% growth y/y) with 53% of those placements being the next-gen dV5 system (which has accelerating placement growth) along with meaningful margin improvements. ISRG has close to 12,000 da Vinci's deployed. Seems like a lot until you realize a hospital with enough beds and surgeries to financially justify having a da Vinci is close to 25,000 worldwide and many hospitals that have a robot are extremely willing to upgrade to next-gen versions. ISRG is in the early innings of their European, Asian (ex. Japan) LatAm, and Middle East expansion. They only just signed a direct distribution deal in Italy, Spain, and Portugal.
ISRG will likely see a lot more multiple compression.
I can't bring myself to sell PRCT but I want to be put out of my misery. I wish ISRG would just buy them up. Feels like the AquaBeam and HYDROS robotic systems would fit so well in ISRG's house and they could actually succeed where PRCT is failing (making the razor-and-blade model actually work).
Please review my portfolio 📊 My Current Investment Portfolio Amphenol (APH) 5 shares Buy in at €148.52/share Intuitive Surgical (ISRG) 1 share Buy in at €349.95 Siemens Energy (ENR) 2 shares Buy in at €163.54 SpaceX 2 shares Buy in at €94.60 NVIDIA (NVDA) 1 share Buy in at €175.52 Marvell Technology (MRVL) 1 share Buy in at €167.18 Palantir (PLTR) 1 share Buy in at €108.44 Below are for long term investments, (Set and forget) Vanguard FTSE All-World (Acc) - monthly 300 Euros Xtrackers MSCI World Small Cap (Acc) - Monthly 100 Euros
I think ISRG just had their big pullback, long term forecast is bullish.
Yeah for Pharma/Medtech I run ISRG, DSNKY and LLY, with a small bet on CNTX because of valuable IP.
Gotcha, yeah they're an incredible company, the future is bright. I had a target weight of 4% for my entire portfolio but they're up to like 6% at the moment so causing some drag but not a ton. I structured my brokerage to have multiple bets within each sector, so while ISRG goes down DSNKY goes up, etc
ISRG is starting to recover, hooray for Dr. Clanker :')
PRCT growing faster at this stage but ISRG had whole robotic surgery market to itself basically, now there is lot more competition for urology robots
META has no value to extract anymore, you should be thinking about investing in a tech company with a tangible product. ISRG is incredibly undervalued right now, and the surgical robotics space is likely to explode in the next few years
Why do you just constrain yourself to forward PE in isolation. First test what revenue growth assumption does it undergo. Then assess if this growth is viable. Then assess their marketcap + addressable marketcap. Test what part of addressable marketcap will be taken by NVDIA at this YoY growth. Test against peers share. Then confirm that this split makes sense. Finally if you are feeling brave, assess what would happen if growth were to stall or to slowdown. Take a look at ISRG as an example. Its revenue and FCF is growing annually, while stock price is dropping. Why? Because growth within its market is slowing down and competition enters.
Moment of silence for ISRG over the past 6 months.
I own a few stocks that roughly fit this description. BSX, ISRG, NOW, & ORCL I've purchased all at recent lows after major dips and still hold. Adobe is another one I bought just under 200/share but have since taken profit.
Can $WDAY $ISRG $IBM make revenue like $MU $42 Billion per quarter?
Just added to QXO (7% more shares), PRCT (13%), ISRG (6%), and NTDOY (13%). Nintendo is now my 2nd largest position (trailing MELI) by total cost basis (ex. ETFs which are \~1/2 of my total cost basis overall). My bull case on Nintendo: * Memory costs are cyclical and the JPY 100B FY27 guidance headwind from memory is transient * NTDOY guidance is legendarily conversative (some may even say outright sandbagging) * IP monetization is early (just 3% or total revenue) and will be a huge driver over the next decade * Install base of 100MM annual playing users drivers huge revenue regardless of future hardware sales * $14.3B is cash with zero debt. They can weather cyclical downturns, fund acquisitions, accelerate IP development, or just increase dividends Plenty can go wrong. I'm betting over the next 10+ years, they go right.
SNPS , CDNS and ISRG hit the lowest last Friday , they are rebounding now .
Hah, ISRG🪦ER already happened for me, too slow
…if I didn’t lose everything with ISRG🪦, I’d probably be out today instead of watching this boring AF final
ISRG calls might save me this week
Unless you YOLO’d ISRG 😎 Now I’ve nothing to look forward to @ all
$ISRG look last 6 quarters earnings, this earnings and revenue still all time high. AI-Algo swing stocks and index $SPY $QQQ big up and down, media feed some scam news, then Algo move big to stocks & index nowadays. https://preview.redd.it/qa9gnu5lnvdh1.png?width=755&format=png&auto=webp&s=aa3c7f47bd747a5a0fc673a344aa2870dc90ec0f
ISRG is the only one that I like, or have ever invested in for medical robotics. I don't get into med stuff too often. I own LLY and had a position in EW years ago. The moat for ISRG is what I've always found attractive. Surgical residents train on the equipment. Switching over once your an attending is time that they don't want to spend when they're already familiar with existing infrastructure. As others have discussed in this thread there is a premium to be paid for this stock. I think the moat is secure and the premium is still worth paying for now. The big pile of cash ISRG has also doesn't hurt.
What is your opinion on BSX? I was considering it as an alternative to ISRG, then decided that the company has less potential long-term growth as well as weaker financials.
$ISRG Earning not bad. Look trend last 5-6 years, time to load it at red days. As baby boomers get old, more health care needs for robotics surgery. https://preview.redd.it/7e0v70kj2vdh1.png?width=1676&format=png&auto=webp&s=bf8ba0153eca29c3a9e31e4a466deae9954e3c7c
More AI use in Robotic surgery, good for $ISRG $UNH $ISRG too many baby boomers spending big at old days, no one going China for health safety and treatment. $ISRG earnings not bad. $MU $SNDK $STX recover with $SOXX
$UNH $ISRG too many baby boomers spending big at old days
$ISRG no one going China for Robotic surgery
ISRG leaps IV is 38%. Loaded up
Yeah, I was going back and forth with AMKR and ISRG this morning. Still hoping for ISRG to sell off a bit more, but just like the fundamentals a bit more on AMKR. I'm there with you though!
Been watching this one for a bit. Going 50/50 on this and ISRG. 350 was my target price
I added more today as well. I'm not in the medical field but my spouse is and regularly uses a da Vinci. As you mentioned and she says, hospitals won't change once they have one in the door. Too much capex re-training physicians. ISRG is one of the best razor-and-blade companies out there.
Only real argument towards long term tailwinds is Chinese competition but that still gives them ROTW growth to play for, where what really matters is physician training and lock in. Exciting times and I bought more ISRG today. I worked in Medical Robotics, and it was always shocking to me how much untapped growth there is in this space. ISRG is one of those firms where the terminal growth rate is usually understated and it affects how people model the company.
Meh, disagree. Bariatric surgeries are a small slice of ISRG's procedure mix. GLP-1s have essentially no impact on prostatectomy, hysterectomy, colorectal resection, hernia repair, oncology procedures, etc. etc. and those are the real volume drivers. I'd like to see someone Ozempic their way out of prostate cancer or a uterine fibroid.
The saturation argument has been made since 2015 and continues to ignore actual data. A market approaching saturation 468 systems placed (18% growth y/y) with 53% of those placements being the next-gen dV5 system (which has accelerating placement growth) along with meaningful margin improvements. ISRG has close to 12,000 da Vinci's deployed. Seems like a lot until you realize a hospital with enough beds and surgeries to financially justify having a da Vinci is close to 25,000 worldwide. ISRG is in the early innings of their European, Asian (ex. Japan) LatAm, and Middle East expansion. They only just signed a direct distribution deal in Italy, Spain, and Portugal. And that doesn't even touch on Ion system and procedure growth and the optionality both systems have as their tech gets better and expands into other surgery types. If you want to argue against ISRG, stick with the overvalued argument. Heck, you could even throw in tariff exposure and potential hospital capex pullbacks when the next recession finally arrives but those are short-term obstacles. Arguing saturation just makes it feel like you don't actually have any knowledge of ISRG outside of their valuation.
ISRG getting absolutely wrecked. I think investors are seeing that it's very overvalued and their market is heading towards saturation
Welp, headed to WEN👩🦰 to supplement these ISRG🪦 losses
Yeah? How did that work out for ASML, TSM, Netflix and ISRG so far? They all tanked before earnings and tanked more after
Invested 25% of my newer portfolio of it in 2006 and haven't sold a share to date. Latest sentiment also driven by potential condition from Medtronic, plus reports of robotic surgery from bipedal robots. $ISRG still has a curve 10 year lead in most fields of this highly regulated industry, plus a strong moat around trained surgeons. Valuation will do whatever it does, company fundamentals are going in the right direction, and that's what I'm tracking.
Definitely finding some stuff I want to get into. NFLX is looking kinda juicy after solid earnings and a big dip. ISRG still very expensive but just cool as fuck. I dont know if I want to even sell a OOTM put on this but its definitely something to watch. If it flounders down to around 300 maybe.
The stock is down because some hospital companies have commented in their earnings that procedures are below expectations. If you like ISRG, look at PRCT. It is like ISRG 20 years ago.
Careful, people over in r/Valueinvesting are bullish on ORCL IBM ISRG NFLX [https://www.reddit.com/r/ValueInvesting/comments/1uyl1m7/blue\_chip\_stocks\_on\_sale\_right\_now/](https://www.reddit.com/r/ValueInvesting/comments/1uyl1m7/blue_chip_stocks_on_sale_right_now/)
I owned a large number of shares of this ticker years (a decade?) ago, and I have to say that I am so glad I dumped everything and bought AAPL. I say this as people looking to buy ISRG should buy AAPL instead, even today.
Phew, just finished a 16 hour shift, exhausted 🥵 But good thing I put my entire IRA into ISRG @ $401.50 before close, I’m definitely rich now because they’ll beat their ER tomorrow 😁🤑
Why did ISRG shut the bed, they had better than estimated earnings and good outlook for year…? Analyst estimates like 100 above where it’s trading. Nuts
Wow. $ISRG with a $50 drop on beat and raise lmao. Had a call and almost bought a put to hedge but decided against it last minute. Smh.
ISRG wtf are you doing down there??
Decided to be unique and not play NFLX like everyone else, so I bought ISRG calls. 🤡 Jokes on me, turns out they're both just ways to destroy money
ISRG - great earnings. Files bankruptcy and about to be delisted.
ISRG just keeps getting hammered. Guess I’m a community member now
**Intuitive (Nasdaq: ISRG)** reported second quarter 2026 revenue of **$2.89 billion**, up **19%** from $2.44 billion a year earlier, driven by approximately **16%** growth in combined da Vinci and Ion procedures and higher system leasing revenue. GAAP net income attributable to Intuitive was **$818 million** or **$2.29** per diluted share, while non-GAAP net income was **$1.00 billion** or **$2.80** per diluted share, both including a **$28 million** net tariff refund benefit. Intuitive placed **468** da Vinci systems and **55** Ion systems, expanding the da Vinci installed base to **11,710** and Ion to **1,096**. Cash, cash equivalents, and investments rose to **$8.63 billion**. For full-year 2026, the company projects worldwide da Vinci procedure growth of **13.5%–15.5%**, non-GAAP gross margin of **68%–69%** of revenue, and non-GAAP operating expense growth of **11%–13%**.
I almost bought calls on ISRG. Thank god I didn’t 💀💀💀💀
ISRG pretty good numbers. Send it to hell
Anyone playing ISRG? This thing is a big mover on earnings. Got a call.
Well that's kind of the issue right? The whole software thing. Don't get me wrong, I think the risk / reward is pretty good at this price but it's not like I'm gonna full port into a falling knife. That's what I have NFLX for. And MSFT. And ISRG. And and and and
Jesus Christ, ISRG. You're equipment is supposed to save lives not make your stock bleed to death.
ISRG looking very interesting at these levels. I might have to take profits to DUOL to double down on them.
ISRG the money printer when they’re not doing recalls
QCOM and DIS, was too boring after owning it for almost 11 years barely did anything. ISRG, yet another boring stock. MELI, needs more volatility. Alot of opportunity cost else where, would rather now just throw it into dividend income funds if i knew these companies were this boring....
Robotics. Next phase of ai is automation. SYM, SERV, PDYN, TER, ISRG, AVAV
I’ve been posting that right now it’s IBM and ISRG going into their earnings. Looking for IBM to reach ATH and ISRG to top $500/share
Rotation, quality growth was all up big. V MA ISRG SPGI RACE and suchlike
Pls tell me if my port is good: AMD, ORCL, META, MSFT, ANET, ISRG, SPCX, GOOG, AMZN, AVGO, PLTR
Robotics. SERV, KDK, ISRG. Might as well hold these bags.